Thymectomy and Immunity in Congenital Heart Disease

先天性心脏病的胸腺切除术和免疫

基本信息

  • 批准号:
    6927582
  • 负责人:
  • 金额:
    $ 10.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long term impact of thymectomy during the period of immunologic maturation in early childhood has not been investigated. A cohort of children and young adults with congenital heart disease is forming in whom incidental thymectomy was performed early in life. There is currently no consensus in surgical practice regarding excising or sparing the thymus in young children undergoing cardiac surgery. Historically the thymus was thought to begin involution in childhood and to be non-functional by adulthood, thus presenting no contraindication to the routine practice of thymectomy during cardiothoracic surgery. Newer investigative techniques, however, have allowed demonstration of thymic activity well into adulthood and revealed the necessity of thymic function for immune reconstitution following cancer chemotherapy and for induction of allograft tolerance following solid organ transplantation. We hypothesize that incidental thymectomy during cardiothoracic surgery in infancy causes long term changes in the cellular immune system. Based on previous evidence and preliminary data we propose both retrospective and prospective longitudinal studies in an ethnically diverse population of children and young adults with congenital heart disease to determine the impact of infant thymectomy on peripheral lymphocyte pools and measures of cellular immune function. In the context of K08 program of development, the specific aims are as follows: Aim 1: To measure effects of thymectomy on the generation and maintenance of the peripheral T lymphocyte populations. We will determine the size of key lymphocyte populations and examine parameters of premature immune senescence. Aim 2: To measure effects of thymectomy on cellular and humoral immunity and T cell receptor diversity. Responsiveness to childhood vaccines will be evaluated and the breadth of the effector T cell repertoire will be measured. These studies will provide the investigator with experience which will be applied to future investigations of immune dysregulation in the context of cardiac transplantation in children.
描述(由申请人提供):尚未研究在儿童早期免疫成熟期进行胸腺切除术的长期影响。一组患有先天性心脏病的儿童和年轻人正在形成,他们在生命早期进行了偶然的胸腺切除术。目前在外科实践中,对于接受心脏手术的幼儿切除或保留胸腺没有达成共识。历史上,胸腺被认为在儿童时期开始退化,到成年时无功能,因此在心胸外科手术中常规进行胸腺切除术没有禁忌症。然而,较新的研究技术,允许证明胸腺的活动以及进入成年期,并揭示了胸腺功能的必要性,免疫重建后癌症化疗和诱导同种异体移植物耐受后实体器官移植。我们假设婴儿期心胸外科手术中偶然的胸腺切除会引起细胞免疫系统的长期变化。根据之前的证据和初步数据,我们建议对患有先天性心脏病的种族多样的儿童和年轻人群体进行回顾性和前瞻性纵向研究,以确定婴儿胸腺切除术对外周淋巴细胞库和细胞免疫功能测量的影响。 在K08发展计划的背景下,具体目标如下: 目的1:探讨胸腺切除对外周血T淋巴细胞生成和维持的影响。我们将确定关键淋巴细胞群体的大小,并检查过早免疫衰老的参数。 目的2:探讨胸腺切除对机体细胞免疫、体液免疫和T细胞受体多样性的影响。将评估对儿童疫苗的反应性,并测量效应T细胞库的宽度。 这些研究将为研究者提供经验,这些经验将应用于儿童心脏移植背景下免疫失调的未来研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY J HALNON其他文献

NANCY J HALNON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY J HALNON', 18)}}的其他基金

EFFECTS OF THYMECTOMY DURING CARDIOTHORACIC SURGERY
胸腺切除术在心胸外科手术中的影响
  • 批准号:
    7951543
  • 财政年份:
    2009
  • 资助金额:
    $ 10.56万
  • 项目类别:
Thymectomy and Immunity in Congentital Heart Disease
先天性心脏病的胸腺切除术和免疫
  • 批准号:
    7033844
  • 财政年份:
    2005
  • 资助金额:
    $ 10.56万
  • 项目类别:
Thymectomy and Immunity in Congenital Heart Disease
先天性心脏病的胸腺切除术和免疫
  • 批准号:
    7618480
  • 财政年份:
    2005
  • 资助金额:
    $ 10.56万
  • 项目类别:
Thymectomy and Immunity in Congenital Heart Disease
先天性心脏病的胸腺切除术和免疫
  • 批准号:
    7225249
  • 财政年份:
    2005
  • 资助金额:
    $ 10.56万
  • 项目类别:
Thymectomy and Immunity in Congenital Heart Disease
先天性心脏病的胸腺切除术和免疫
  • 批准号:
    7383775
  • 财政年份:
    2005
  • 资助金额:
    $ 10.56万
  • 项目类别:
Thymus Function in Children after Cardiothoracic Surgery
心胸外科手术后儿童的胸腺功能
  • 批准号:
    7043134
  • 财政年份:
    2003
  • 资助金额:
    $ 10.56万
  • 项目类别:

相似海外基金

Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 10.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 10.56万
  • 项目类别:
    Discovery Projects
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 10.56万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 10.56万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 10.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 10.56万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 10.56万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 10.56万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 10.56万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 10.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了